Skip to content

pharmaceuticals.co.nz

Drugs, medicines and medical news
Main navigation

Month: October 2024

Common drug shows promise in extending lifespan

Scientists say mifepristone, used in cancer and reproductive care, could pave the way for anti-aging treatments.

October 25, 2024 Uncategorized

Tackling structural racism in health for London

A new report on structural racism and health inequalities in London by Michael Marmot and colleagues at the […]

October 25, 2024 Uncategorized

Sixty seconds on . . . fixing the NHS

Is it broken?Have you been living under a rock? The government has talked about little else since taking […]

October 25, 2024 Uncategorized

CBT for postnatal depression … and other research

Culturally adapted CBT for postnatal depressionStigma, language, and cultural barriers make it harder for women from minority ethnic […]

October 25, 2024 Uncategorized

Mpox risk to Europe “low” says EU official, but virus and bird flu need monitoring

How concerned are you about the ongoing mpox outbreak?1We at the European Centre for Disease Prevention and Control […]

October 25, 2024 Uncategorized

Tiny medicine combats infections and drug resistance

Researchers have developed a new technology that can hold an entire course of antibiotics in one tiny dose […]

October 25, 2024 Uncategorized

Unnoticeable electric currents could reduce skin infections

Using a few zaps of electricity to the skin, researchers can stop bacterial infections without using any drugs. […]

October 25, 2024 Uncategorized

Daylight saving time harms health and increases inequalities

Daylight saving time, a seasonal hour shift in clock time, is a legislative policy followed by about 70 […]

October 24, 2024 Uncategorized

Sunset cataract

A man in his early 50s presented with a three year history of gradually worsening vision in the […]

October 24, 2024 Uncategorized

Intensive chemotherapy versus standard chemotherapy among patients with high risk, operable, triple negative breast cancer based on integrated mRNA-lncRNA signature (BCTOP-T-A01): randomised, multicentre, phase 3 trial

AbstractObjectiveTo evaluate the feasibility of using a multigene signature to tailor individualised adjuvant therapy for patients with operable […]

October 24, 2024 Uncategorized

Posts navigation

Posts pagination

« Previous 1 … 3 4 5 … 18 Next »
Proudly powered by WordPress | Theme: Hive Lite by Pixelgrade.
Footer navigation
  • Privacy Policy